Correlation Between GlaxoSmithKline PLC and Vanguard Intermediate-ter
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Vanguard Intermediate-ter at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Vanguard Intermediate-ter into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Vanguard Intermediate Term Tax Exempt, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Vanguard Intermediate-ter and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Vanguard Intermediate-ter. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Vanguard Intermediate-ter.
Diversification Opportunities for GlaxoSmithKline PLC and Vanguard Intermediate-ter
0.35 | Correlation Coefficient |
Weak diversification
The 3 months correlation between GlaxoSmithKline and Vanguard is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Vanguard Intermediate Term Tax in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vanguard Intermediate-ter and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Vanguard Intermediate-ter. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vanguard Intermediate-ter has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Vanguard Intermediate-ter go up and down completely randomly.
Pair Corralation between GlaxoSmithKline PLC and Vanguard Intermediate-ter
Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to under-perform the Vanguard Intermediate-ter. In addition to that, GlaxoSmithKline PLC is 5.44 times more volatile than Vanguard Intermediate Term Tax Exempt. It trades about -0.3 of its total potential returns per unit of risk. Vanguard Intermediate Term Tax Exempt is currently generating about 0.15 per unit of volatility. If you would invest 1,357 in Vanguard Intermediate Term Tax Exempt on August 28, 2024 and sell it today you would earn a total of 11.00 from holding Vanguard Intermediate Term Tax Exempt or generate 0.81% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
GlaxoSmithKline PLC ADR vs. Vanguard Intermediate Term Tax
Performance |
| Timeline |
| GlaxoSmithKline PLC ADR |
| Vanguard Intermediate-ter |
GlaxoSmithKline PLC and Vanguard Intermediate-ter Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with GlaxoSmithKline PLC and Vanguard Intermediate-ter
The main advantage of trading using opposite GlaxoSmithKline PLC and Vanguard Intermediate-ter positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Vanguard Intermediate-ter can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vanguard Intermediate-ter will offset losses from the drop in Vanguard Intermediate-ter's long position.| GlaxoSmithKline PLC vs. Novartis AG ADR | GlaxoSmithKline PLC vs. AstraZeneca PLC ADR | GlaxoSmithKline PLC vs. Roche Holding Ltd | GlaxoSmithKline PLC vs. Bristol Myers Squibb |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |